Tags

Type your tag names separated by a space and hit enter

Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies.
Cell Mol Immunol. 2020 10; 17(10):1098-1100.CM

Authors+Show Affiliations

Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. Qianyang Biomedical Research Institute, Guangzhou, Guangdong, China. Institute of Pediatrics Guangzhou Women and Children Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China. gz8hlf@126.com.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. dengkai6@mail.sysu.edu.cn.Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. zhangh92@mail.sysu.edu.cn.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32939033

Citation

Liu, Bingfeng, et al. "Recovered COVID-19 Patients With Recurrent Viral RNA Exhibit Lower Levels of anti-RBD Antibodies." Cellular & Molecular Immunology, vol. 17, no. 10, 2020, pp. 1098-1100.
Liu B, Shi Y, Zhang W, et al. Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies. Cell Mol Immunol. 2020;17(10):1098-1100.
Liu, B., Shi, Y., Zhang, W., Li, R., He, Z., Yang, X., Pan, Y., Deng, X., Tan, M., Zhao, L., Zou, F., Zhang, Y., Pan, T., Zhang, J., Zhang, X., Xiao, F., Li, F., Deng, K., & Zhang, H. (2020). Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies. Cellular & Molecular Immunology, 17(10), 1098-1100. https://doi.org/10.1038/s41423-020-00528-0
Liu B, et al. Recovered COVID-19 Patients With Recurrent Viral RNA Exhibit Lower Levels of anti-RBD Antibodies. Cell Mol Immunol. 2020;17(10):1098-1100. PubMed PMID: 32939033.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies. AU - Liu,Bingfeng, AU - Shi,Yaling, AU - Zhang,Wanying, AU - Li,Rong, AU - He,Zhangping, AU - Yang,Xiaofan, AU - Pan,Yuejun, AU - Deng,Xilong, AU - Tan,Mingkai, AU - Zhao,Lingzhai, AU - Zou,Fan, AU - Zhang,Yiwen, AU - Pan,Ting, AU - Zhang,Junsong, AU - Zhang,Xu, AU - Xiao,Fei, AU - Li,Fang, AU - Deng,Kai, AU - Zhang,Hui, Y1 - 2020/09/16/ PY - 2020/07/28/received PY - 2020/08/04/accepted PY - 2020/9/18/pubmed PY - 2020/10/21/medline PY - 2020/9/17/entrez SP - 1098 EP - 1100 JF - Cellular & molecular immunology JO - Cell Mol Immunol VL - 17 IS - 10 SN - 2042-0226 UR - https://www.unboundmedicine.com/medline/citation/32939033/Recovered_COVID_19_patients_with_recurrent_viral_RNA_exhibit_lower_levels_of_anti_RBD_antibodies_ L2 - https://doi.org/10.1038/s41423-020-00528-0 DB - PRIME DP - Unbound Medicine ER -